A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 35/14 (2006.01) A61P 31/10 (2006.01) A61P 37/04 (2006.01)
Patent
CA 2649290
A method for stimulating the immune system in immunocompromised patients in order to treat opportunistic infection. The method involves the infusion of intentionally mismatched allogeneic cells. In order to prevent graft vs. host disease complications, the allogeneic cells can be irradiated prior to infusion.
L'invention concerne une méthode pour stimuler le système immunitaire de patients immunocompromis afin de traiter une infection opportuniste. La méthode comprend la perfusion de cellules allogènes intentionnellement mal assorties. Afin de prévenir les complications d'une maladie greffe contre hôte, les cellules allogènes peuvent être irradiées avant perfusion.
Har-Noy Michael
Bereskin & Parr Llp/s.e.n.c.r.l.,s.r.l.
Immunovative Therapies Ltd.
LandOfFree
Allogeneic cell therapy for treatment of opportunistic... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Allogeneic cell therapy for treatment of opportunistic..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Allogeneic cell therapy for treatment of opportunistic... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1430683